Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by O12009on Jan 20, 2020 4:14pm
173 Views
Post# 30574852

RE:RE:RE:RE:RE:Junk Mail

RE:RE:RE:RE:RE:Junk Mail
Quattro74 wrote: Yep Laser, Especially since TLT had that FDA 'pre-IND meeting'. No idea what is holding this up? Probably some language isn't right in some piece of the application? :-( 

LaserStock29 wrote:
Quattro74 wrote: Nope, we are all good in Canada. Treated #6 I think since the FDA hold? Anyway I don't think the FDA is linked to Canada in that way.



The connection between the FDA and HC is the bilateral 'standards' agreement on what consistutes 'bladder cancer' between institutions.. i.e. how it's classified and standard of care. 

Having our 'all-star' cast of doctors.. greatly should work to our benefit.. a couple of them helped 'consult' on the very legislation regarding bladder cancer.


So it's a blasted mystery how and why this was ever given a 'clinical hold' 

maybe the so called 'timing' just wasn't right... *rolls eyes*



Do we even know if TLT resubmitted the indication they maybe waiting so it brings us all closer to March4
Bullboard Posts